Given that the primary sources of VEGFC in the dura mater are blood vessel smooth muscle cells, pineal gland, and pituitary gland,9 the lack of changes to mRNA transcript levels of Vegfc/d following CLL treatment was not unexpected. This evidence concerns the gene VEGFC and B-cell chronic lymphocytic leukemia.